130 related articles for article (PubMed ID: 16586462)
1. Investigation of the potential pharmacokinetic and pharmaco-dynamic drug interaction between AHN 1-055, a potent benztropine analog used for cocaine abuse, and cocaine after dosing in rats using intracerebral microdialysis.
Raje S; Cornish J; Newman AH; Cao J; Katz JL; Eddington ND
Biopharm Drug Dispos; 2006 Jul; 27(5):229-40. PubMed ID: 16586462
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic/pharmacodynamic modeling.
Raje S; Cornish J; Newman AH; Cao J; Katz JL; Eddington ND
Pharm Res; 2005 Apr; 22(4):603-12. PubMed ID: 15846468
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques.
Raje S; Cao J; Newman AH; Gao H; Eddington ND
J Pharmacol Exp Ther; 2003 Nov; 307(2):801-8. PubMed ID: 12966155
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling.
Othman AA; Newman AH; Eddington ND
J Pharmacol Exp Ther; 2007 Aug; 322(2):760-9. PubMed ID: 17519385
[TBL] [Abstract][Full Text] [Related]
6. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
Katz JL; Kopajtic TA; Agoston GE; Newman AH
J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics, brain distribution, and pharmacodynamics of 2nd generation dopamine transporter selective benztropine analogs developed as potential substitute therapeutics for treatment of cocaine abuse.
Syed SA; Newman AH; Othman AA; Eddington ND
J Pharm Sci; 2008 May; 97(5):1993-2007. PubMed ID: 17879975
[TBL] [Abstract][Full Text] [Related]
8. Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine.
Tanda G; Ebbs A; Newman AH; Katz JL
J Pharmacol Exp Ther; 2005 May; 313(2):613-20. PubMed ID: 15681658
[TBL] [Abstract][Full Text] [Related]
9. Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats.
Li SM; Newman AH; Katz JL
J Pharmacol Exp Ther; 2005 Jun; 313(3):1223-30. PubMed ID: 15743929
[TBL] [Abstract][Full Text] [Related]
10. Application of triple-probe microdialysis for fast pharmacokinetic/pharmacodynamic evaluation of dopamimetic activity of drug candidates in the rat brain.
Weikop P; Egestad B; Kehr J
J Neurosci Methods; 2004 Dec; 140(1-2):59-65. PubMed ID: 15589335
[TBL] [Abstract][Full Text] [Related]
11. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
Desai RI; Kopajtic TA; French D; Newman AH; Katz JL
J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753
[TBL] [Abstract][Full Text] [Related]
12. Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole.
Newman AH; Kulkarni S
Med Res Rev; 2002 Sep; 22(5):429-64. PubMed ID: 12210554
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs.
Campbell VC; Kopajtic TA; Newman AH; Katz JL
J Pharmacol Exp Ther; 2005 Nov; 315(2):631-40. PubMed ID: 16055673
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine.
Raybon JJ; Boje KM
J Pharmacol Exp Ther; 2007 Mar; 320(3):1252-60. PubMed ID: 17138862
[TBL] [Abstract][Full Text] [Related]
15. The novel N-substituted benztropine analog GA2-50 possesses pharmacokinetic and pharmacodynamic profiles favorable for a candidate substitute medication for cocaine abuse.
Othman AA; Newman AH; Eddington ND
J Pharm Sci; 2008 Dec; 97(12):5453-70. PubMed ID: 18425847
[TBL] [Abstract][Full Text] [Related]
16. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
17. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.
Velázquez-Sánchez C; Ferragud A; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
Neuropsychopharmacology; 2009 Nov; 34(12):2497-507. PubMed ID: 19606084
[TBL] [Abstract][Full Text] [Related]
18. A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.
Ferragud A; Velázquez-Sánchez C; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
Psychopharmacology (Berl); 2009 Dec; 207(2):281-9. PubMed ID: 19756525
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.
Velazquez-Sanchez C; Ferragud A; Renau-Piqueras J; Canales JJ
Int J Neuropsychopharmacol; 2011 Jun; 14(5):655-65. PubMed ID: 20735880
[TBL] [Abstract][Full Text] [Related]
20. Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.
Hiranita T; Soto PL; Newman AH; Katz JL
J Pharmacol Exp Ther; 2009 May; 329(2):677-86. PubMed ID: 19228996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
